CARMEL, IND. (PRWEB) SEPTEMBER 11, 2018
Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the University of Nevada, Reno for a key nanosurface technology patent covering the use of ceramics on implants with nanopores.
This foundational patent allows development of ceramics for medical implants with nanosurfacing that enhances cell binding and drug delivery depending on the purpose of implantation.
The ceramic nanosurfacing technology dovetails with Nanovis’ technology, offering a range of spinal implant nanosurfaces designed to increase bone to implant growth. The addition of ceramic nanosurfacing allows Nanovis to extend its lead in the development of superior fixation technology for medical implants with greater strength, osseointegration and bactericidal properties.
“We are delighted to work with the University of Nevada, Reno on this nanotechnology,” says Matt Hedrick, Nanovis CEO. “Adding ceramics to nanopores provides important capabilities to influence cells attaching to the surface and for drug delivery. This technology used in combination with our nanotube surface will further bolster our portfolio of interbodies, screws and other implants as the superior fixation technology choice for surgeons to heal their patients and distributors to grow their business.”
The company’s technology already offers interbodies with the best combination of deeply porous bone interface scaffold and bridging bone visualization with a nanotube surface. Adding nanoscale ceramic technology further advances Nanovis’ surface technology lead and extends the company’s portfolio of implant offering the superior fixation technology choice.
“We can control the length, the height, the pore openings and the pore volumes within the ceramic nanosurface,” says Mano Misra, professor of materials science and engineering at the University of Nevada, Reno. “The sizes and shapes of the nanosurface pores can be changed so the ceramic coating releases drugs over a longer period of time, providing superior anti-infection properties.”
“Bringing discoveries into the marketplace is the way that university research benefits society,” says Ellen Purpus, University of Nevada, Reno assistant vice president for Enterprise & Innovation.
For more information about how to help patients, or better serve surgeons with Nanovis’ nanotechnologies, please visit us during the North American Spine Society (NASS) 2018 meeting September 26-29 in Los Angeles at Booth #2260 or call 1-317-507-1058.
For more information about distribution opportunities, please contact Jeff Shepherd, Vice President of Sales, at jeff.shepherd(at)nanovistechnology(dot)com.
About Nanovis
Nanovis’ mission is to develop science-enhanced, life-improving technologies. The Company’s patented and proprietary regenerative technology platforms provide differentiated surface advantages enabling the potential for existing medical devices to achieve new outcomes. Focused on aggressive, sustainable growth across multiple markets, Nanovis is commercializing science-driven platforms: the deeply porous scaffold currently available with the FortiCore® line of interbody fusion devices; an advanced nano-surface technology in development; and a surface technology with anti-colonization and anti-microbial capabilities in pre-clinical studies.
About University of Nevada, Reno
Nevada’s land-grant university founded in 1874, the University of Nevada, Reno ranks in the top tier of best national universities by U.S. News and World Report and is steadily growing in enrollment, excellence and reputation. The University serves more than 22,000 students. Part of the Nevada System of Higher Education, the University is home to the University of Nevada, Reno School of Medicine and University of Nevada Cooperative Extension. Through a commitment to world-improving research, student success and outreach benefiting the communities and businesses of Nevada, the University has impact across the state and around the world. For more information, visit http://www.unr.edu.
